pharma.markets

pharma.markets

  • HOME
  • Imprint

merck

Merck Completes Acquisition of the Chemical Business of Mecaro

02/01/2023 MaP 0

Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business. […]

Merck Invests € 290 Million in U.S. Drug Safety Testing Capacity

16/11/2022 MaP 0

• Responds to growing global demand for biosafety testing as essential requirement for drug development and commercialization • Expansion creates more than 500 new jobs […]

Merck launches new marine cosmetic ingredients during in-cosmeticsTM Asia 2022

03/11/2022 MaP 0

Merck presents two new cosmetic active ingredients for the Asian Pacific market at this year’s in-cosmetics™ Asia that takes place in Bangkok from Nov 1-3: […]

Gerresheimer and Merck jointly developed a digital twin solution …

27/10/2022 MaP 0

….to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. • Proof of Concept (PoC) successfully provides primary packaging with a […]

Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care

26/10/2022 MaP 0

Merck will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). • Company’s scientific leadership […]

Merck Highlights New Data for Evobrutinib…

26/10/2022 MaP 0

…First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment This data suggests the long-term positive […]

Merck has launched the VirusExpress® 293 Adeno-Associated Virus (AAV) Production Platform

09/08/2022 MaP 0

Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform Merck has launched […]

Merck Announces Collaboration with Agilent Technologies

14/06/2022 MaP 0

…to Fill Industry Gap in Process Analytical Technologies for Downstream Processing Merck today announced that it has entered a collaboration with Agilent Technologies to advance […]

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System

05/04/2022 MaP 0

The acquisition of the MAST® platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit. Merck to become first company to offer […]

Merck today announced several organizational changes and a new operating model to support the long-term growth strategy

08/02/2022 MaP 0

….of the Life Science business sector. • New operating model to accelerate profitable growth strategy • Newly formed Life Science Services business unit to offer […]

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

06/01/2022 MaP 0

Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted […]

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million

09/12/2021 MaP 0

Merck today announced the expansion of its strategic, corporate venture capital arm M Ventures. Merck, a leading science and technology company, today announced the expansion […]

Merck Invests € 270 Million in a New Research Center and Vocational & Advanced Training in Darmstadt

19/07/2021 MaP 0

Merck plans to invest € 270 million at its global headquarters in Darmstadt by building a new Translational Science Center for its Healthcare business sector […]

Merck Announces Investment of EUR 20 million to Expand its R&D and Manufacturing Site in Shizuoka, Japan

15/04/2021 MaP 0

Merck, a leading science and technology company, today announced an investment of EUR 20 million to expand research and development and manufacturing capabilities at its […]

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

17/03/2021 MaP 0

Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]

Posts navigation

1 2 3 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • Cosmetics
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • Innovation
  • Mental Health
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Therapy
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

Archive

  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

    04/02/2023 0
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer

    04/02/2023 0
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

    02/02/2023 0
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

    27/01/2023 0
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

    26/01/2023 0
Archives
  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 economy elpais.com emergency eu europe european fda food global guarantee health hygiene investment links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support test vaccine who

Copyright © 2023 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner